cGMP PKG signaling pathway
| Catalog | Product | Reactivity | Application | Citations |
|---|---|---|---|---|
| BF3453 | AGTR1 Recombinant mAb | Human, Mouse, Rat | WB | 0 |
| BF3643 | NFAT1 Recombinant mAb | Human | WB | 0 |
| BF3614 | P-Phospholamban (Ser16) Recombinant mAb | Human, Mouse | WB | 0 |
| BF3613 | Phospholamban Recombinant mAb | Human, Mouse, Rat | WB, IHC | 0 |
| BF3576 | GATA4 Recombinant mAb | Human, Mouse, Rat | WB, IF/ICC | 0 |
| BF3159 | NPPB Recombinant mAb | Human, Mouse, Rat | IHC | 0 |
| BF3950 | P-ERK1/2 (Thr202/Thr185) Recombinant mAb | Human, Mouse, Rat | WB, IHC, IF/ICC | 0 |
| BF3981 | ATP2A2 Recombinant mAb | Human, Mouse, Rat | WB, IHC, IF/ICC | 0 |
| BF3998 | MEK1/2 Recombinant mAb | Human, Mouse, Rat | WB, IHC, IF/ICC | 0 |
| BF4079 | ATP1B1 Recombinant mAb | Human, Mouse, Rat | WB, IHC | 0 |
| BF4143 | P-ATF2 (Thr71) Recombinant mAb | Human, Mouse | WB, IF/ICC | 0 |
| BF4218 | AKT1/2/3 Recombinant mAb | Human, Mouse, Rat | WB, IF/ICC | 0 |
| BF4221 | P-AKT1/2/3 (Ser473) Recombinant mAb | Human, Mouse, Rat | WB, IF/ICC | 0 |
| BF4123 | MEF2A Recombinant mAb | Human, Mouse, Rat | WB, IF/ICC | 0 |
| BF4157 | Adrenergic Receptor alpha -1B Recombinant mAb | Human, Mouse, Rat | WB, IHC | 0 |
| BF4180 | MEF2C Recombinant mAb | Human, Mouse, Rat | WB, IHC, IF/ICC | 0 |
| BF8004 | ERK1/2 mAb | Mouse, Rat | WB, IHC | 27 |
| BF8028 | CREB mAb | Human, Mouse, Rat | WB, IHC | 4 |
| BF8305 | AKT1 mAb | Human, Rat | WB | 1 |
| BF8131 | VASP mAb | Human, Mouse | WB, IHC | 1 |
| BF8172 | MEF2A mAb | Human, Rat | WB | 0 |
| BF8139 | ATP1A1 mAb | Human, Mouse, Rat | WB | 0 |
| BF8042 | Insulin mAb | Human, Rat | WB, IHC | 0 |
| BF8065 | AGTR1 mAb | Human, Mouse, Rat | WB | 0 |
| BF8163 | ERK1/2 mAb | Human, Mouse, Rat | WB | 0 |
| BF8213 | ROCK2 mAb | Human, Mouse, Rat, Monkey | WB | 0 |
| BF8112 | Insulin Receptor alpha mAb | Human, Mouse | WB | 0 |
| BF8135 | Insulin Receptor beta mAb | Human | IHC | 0 |
| BF8157 | eNOS mAb | Human, Mouse, Rat | WB, IHC | 0 |
| BF8860 | CACNA1C mAb | Human | WB | 0 |